TMS Co., Ltd. (TYO:4891)
Japan · Delayed Price · Currency is JPY 102.00
-1.00 (-0.97%)
Jul 16, 2026, 9:45 AM JST
TMS Co., Ltd. Market Cap
TMS Co., Ltd. has a market cap or net worth of 4.69 billion as of July 15, 2026. Its market cap has decreased by -30.73% in one year.
Market Cap
4.69B
Enterprise Value
2.06B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
102.00
Market Cap Chart
Since November 22, 2022, TMS Co., Ltd.'s market cap has decreased from 28.10B to 4.69B, a decrease of -83.30%. That is a compound annual growth rate of -38.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 4.69B | -20.01% |
| Dec 30, 2025 | 5.87B | -33.26% |
| Dec 30, 2024 | 8.79B | 27.76% |
| Dec 29, 2023 | 6.88B | -69.65% |
| Dec 30, 2022 | 22.68B | -19.29% |
| Nov 22, 2022 | 28.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellSource | 6.91B |
| Carna Biosciences | 6.82B |
| Noile-Immune Biotech | 5.95B |
| PRISM BioLab Co.,LTD | 5.80B |
| Chiome Bioscience | 5.59B |
| Soiken Holdings | 5.55B |
| D. Western Therapeutics Institute | 4.71B |
| Kohjin Bio | 4.40B |